(Q37154799)

18 August 2017

1 reference

title

Maintenance therapy to prevent recurrence of depression: summary and implications of the PREVENT study (English)

1 reference

18 August 2017

Susan G Kornstein

1 reference

18 August 2017

publication date

1 May 2008

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

18 August 2017

published in

1 reference

18 August 2017

1 reference

18 August 2017

1 reference

18 August 2017

page(s)

737-742

1 reference

Multiple recurrences of major depressive disorder.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.5.737

Presenting characteristics of depressed outpatients as a function of recurrence: preliminary findings from the STAR*D clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.5.737

Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.5.737

Fluoxetine in the prevention of depressive recurrences: a double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.5.737

Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo-controlled study of maintenance therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.5.737

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.5.737

The P revention of R ecurrent E pisodes of Depression with Ven lafaxine for T wo Years (PREVENT) Study: Outcomes from the Acute and Continuation Phases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.5.737

21 January 2018

Identifiers

DOI

10.1586/14737175.8.5.737

1 reference

18 August 2017

1 reference